The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
SARASOTA, Fla. (SNN) — The Food and Drug Administration has approved a new Alzheimer’s drug from Eli Lilly. According to Eli ...
The Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a study suggested that it ...
Alzheimer's disease affects millions of Americans as well as their families as they learn to live with their loved one ...
The drug will be available to adults with mild cognitive impairments in the early stages of the disease. The company that ...
A second drug for the treatment of Alzheimer’s disease was approved Tuesday by the Food and Drug Administration. The drug donanemab, marketed by drugmaker Eli Lilly as Kisunla, was tested in a ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
Eli Lilly received FDA approval for a drug to help treat Alzheimer's on Tuesday after studies showed it could help slow the ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...